UPB vs XOM · rev $2.9M vs P/E 24, rev $201.16B
Upstream Bio, Inc. (UPB) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
UPB currently screens at market cap $407.3M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the UPB and XOM stock pages for the full models.
Not investment advice.